Loading…
Carbocyclic Analog of Purine Ribonucleosides with Antileukemic Activity
Carbocyclic analogs of several naturally occurring and biologically active purine nucleosides have been synthesized (1–4). In these analogs a methylene group occupies the position of the ring oxygen atom of the ribo- or deoxyribofuranosides. Because of the presence of a stable carbon-nitrogen bond a...
Saved in:
Published in: | Journal of pharmaceutical sciences 1973-05, Vol.62 (5), p.858-859 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4277-3e5d44f509086f2a67bafd603bb8ac02ac8c12f67364973f1ebc822a92c2b9ff3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4277-3e5d44f509086f2a67bafd603bb8ac02ac8c12f67364973f1ebc822a92c2b9ff3 |
container_end_page | 859 |
container_issue | 5 |
container_start_page | 858 |
container_title | Journal of pharmaceutical sciences |
container_volume | 62 |
creator | Fulmer Shealy, Y. Clayton, Joe D. |
description | Carbocyclic analogs of several naturally occurring and biologically active purine nucleosides have been synthesized (1–4). In these analogs a methylene group occupies the position of the ring oxygen atom of the ribo- or deoxyribofuranosides. Because of the presence of a stable carbon-nitrogen bond at position 9 of the purine moiety, these analogs are not subject to cleavage by enzymes that remove or transfer the ribofuranosyl moiety of the nucleosides or nucleotides. Biochemical studies (5–7) have shown that the racemic analog (III) of adenosine can serve either as a substrate for or as an inhibitor of some of the enzymes involved in purine nucleotide metabolism, one of the more interesting findings being the inhibition of guanylic acid kinase by the phosphate (7). The antibiotic aristeromycin (8). the optically active form (9, 10) of the adenosine analog, inhibits certain plant pathogens (8, 11). Several racemic carbocyclic analogs of purine nucleosides are cytotoxic to neoplastic cells growing in culture (4). In this communication, antileukemic activity in vivo by a carbocyclic analog, the 8-azaadenosine analog (II), is reported. |
doi_str_mv | 10.1002/jps.2600620547 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_81917330</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354915410354</els_id><sourcerecordid>81917330</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4277-3e5d44f509086f2a67bafd603bb8ac02ac8c12f67364973f1ebc822a92c2b9ff3</originalsourceid><addsrcrecordid>eNqFkMFO3DAURa2qFR2gW3aVsuou02cntpMlmrYDCFEErSp1YznOMzVk4sFOgPl7PMqIqouKlRfv3GvdQ8gRhTkFYJ9v13HOBIBgwEv5hswoZ5ALoPItmSWA5QUv6_dkP8ZbSBhwvkf2SglcUpiR5UKHxpuN6ZzJjnvd-ZvM2-xyDK7H7Mo1vh9Nhz66FmP26IY_iRpch-MdrrYRM7gHN2wOyTuru4gfdu8B-fnt64_FSX7-fXm6OD7PTcmkzAvkbVlaDjVUwjItZKNtK6BomkobYNpUhjIrZCHKWhaWYmMqxnTNDGtqa4sD8mnqXQd_P2Ic1MpFg12ne_RjVBWtqSwKSOB8Ak3wMQa0ah3cSoeNoqC25lQyp_6aS4GPu-axWWH7gu9UpXs93R_T-s0rbers8vqf7nzKujjg00tWhzuVpkqufl0sFYeLL9dXv4Xa_lVNPCaVDw6DisZhb7B1Ac2gWu_-N-MZHaCcEg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>81917330</pqid></control><display><type>article</type><title>Carbocyclic Analog of Purine Ribonucleosides with Antileukemic Activity</title><source>Wiley-Blackwell Journals</source><creator>Fulmer Shealy, Y. ; Clayton, Joe D.</creator><creatorcontrib>Fulmer Shealy, Y. ; Clayton, Joe D.</creatorcontrib><description>Carbocyclic analogs of several naturally occurring and biologically active purine nucleosides have been synthesized (1–4). In these analogs a methylene group occupies the position of the ring oxygen atom of the ribo- or deoxyribofuranosides. Because of the presence of a stable carbon-nitrogen bond at position 9 of the purine moiety, these analogs are not subject to cleavage by enzymes that remove or transfer the ribofuranosyl moiety of the nucleosides or nucleotides. Biochemical studies (5–7) have shown that the racemic analog (III) of adenosine can serve either as a substrate for or as an inhibitor of some of the enzymes involved in purine nucleotide metabolism, one of the more interesting findings being the inhibition of guanylic acid kinase by the phosphate (7). The antibiotic aristeromycin (8). the optically active form (9, 10) of the adenosine analog, inhibits certain plant pathogens (8, 11). Several racemic carbocyclic analogs of purine nucleosides are cytotoxic to neoplastic cells growing in culture (4). In this communication, antileukemic activity in vivo by a carbocyclic analog, the 8-azaadenosine analog (II), is reported.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.2600620547</identifier><identifier>PMID: 4705710</identifier><language>eng</language><publisher>Washington: Elsevier Inc</publisher><subject>5-d]pyrimidine (carbocyclic analog of purine nucleoside) ; 5-d]pyrimidines-synthesis of 8-azaadenosine analog of purine nucleoside ; antileukemic activity ; Antileukemic activity-synthesis of a v-triazolo ; Antileukemic activity—synthesis of a v-triazolo[4,5-d]pyrimidine (carbocyclic analog of purine nucleoside) ; Aza Compounds - therapeutic use ; Carbocyclic analogs of purine nucleosides (8- azaadenosine analog)—synthesis, antileukemic activity ; Carbocyclic analogs of purine nucleosides (8-azaadenosine analog)-synthesis ; Carcinoma, Squamous Cell - drug therapy ; Cells, Cultured ; Humans ; Leukemia - drug therapy ; Neoplasms, Experimental - drug therapy ; Purine ribonucleosides-synthesis of carbocyclic analog with antileukemic activity ; Purines - chemical synthesis ; Purines - therapeutic use ; Ribonucleosides - chemical synthesis ; Ribonucleosides - therapeutic use ; Triazoles - therapeutic use ; v-Triazolo ; v-Triazolo[4,5-d]pyrimidines—synthesis of 8-azaadenosine analog of purine nucleoside, antileukemic activity</subject><ispartof>Journal of pharmaceutical sciences, 1973-05, Vol.62 (5), p.858-859</ispartof><rights>1973 Wiley-Liss, Inc., A Wiley Company</rights><rights>Copyright © 1973 Wiley‐Liss, Inc., A Wiley Company</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4277-3e5d44f509086f2a67bafd603bb8ac02ac8c12f67364973f1ebc822a92c2b9ff3</citedby><cites>FETCH-LOGICAL-c4277-3e5d44f509086f2a67bafd603bb8ac02ac8c12f67364973f1ebc822a92c2b9ff3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.2600620547$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjps.2600620547$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/4705710$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fulmer Shealy, Y.</creatorcontrib><creatorcontrib>Clayton, Joe D.</creatorcontrib><title>Carbocyclic Analog of Purine Ribonucleosides with Antileukemic Activity</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>Carbocyclic analogs of several naturally occurring and biologically active purine nucleosides have been synthesized (1–4). In these analogs a methylene group occupies the position of the ring oxygen atom of the ribo- or deoxyribofuranosides. Because of the presence of a stable carbon-nitrogen bond at position 9 of the purine moiety, these analogs are not subject to cleavage by enzymes that remove or transfer the ribofuranosyl moiety of the nucleosides or nucleotides. Biochemical studies (5–7) have shown that the racemic analog (III) of adenosine can serve either as a substrate for or as an inhibitor of some of the enzymes involved in purine nucleotide metabolism, one of the more interesting findings being the inhibition of guanylic acid kinase by the phosphate (7). The antibiotic aristeromycin (8). the optically active form (9, 10) of the adenosine analog, inhibits certain plant pathogens (8, 11). Several racemic carbocyclic analogs of purine nucleosides are cytotoxic to neoplastic cells growing in culture (4). In this communication, antileukemic activity in vivo by a carbocyclic analog, the 8-azaadenosine analog (II), is reported.</description><subject>5-d]pyrimidine (carbocyclic analog of purine nucleoside)</subject><subject>5-d]pyrimidines-synthesis of 8-azaadenosine analog of purine nucleoside</subject><subject>antileukemic activity</subject><subject>Antileukemic activity-synthesis of a v-triazolo</subject><subject>Antileukemic activity—synthesis of a v-triazolo[4,5-d]pyrimidine (carbocyclic analog of purine nucleoside)</subject><subject>Aza Compounds - therapeutic use</subject><subject>Carbocyclic analogs of purine nucleosides (8- azaadenosine analog)—synthesis, antileukemic activity</subject><subject>Carbocyclic analogs of purine nucleosides (8-azaadenosine analog)-synthesis</subject><subject>Carcinoma, Squamous Cell - drug therapy</subject><subject>Cells, Cultured</subject><subject>Humans</subject><subject>Leukemia - drug therapy</subject><subject>Neoplasms, Experimental - drug therapy</subject><subject>Purine ribonucleosides-synthesis of carbocyclic analog with antileukemic activity</subject><subject>Purines - chemical synthesis</subject><subject>Purines - therapeutic use</subject><subject>Ribonucleosides - chemical synthesis</subject><subject>Ribonucleosides - therapeutic use</subject><subject>Triazoles - therapeutic use</subject><subject>v-Triazolo</subject><subject>v-Triazolo[4,5-d]pyrimidines—synthesis of 8-azaadenosine analog of purine nucleoside, antileukemic activity</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1973</creationdate><recordtype>article</recordtype><recordid>eNqFkMFO3DAURa2qFR2gW3aVsuou02cntpMlmrYDCFEErSp1YznOMzVk4sFOgPl7PMqIqouKlRfv3GvdQ8gRhTkFYJ9v13HOBIBgwEv5hswoZ5ALoPItmSWA5QUv6_dkP8ZbSBhwvkf2SglcUpiR5UKHxpuN6ZzJjnvd-ZvM2-xyDK7H7Mo1vh9Nhz66FmP26IY_iRpch-MdrrYRM7gHN2wOyTuru4gfdu8B-fnt64_FSX7-fXm6OD7PTcmkzAvkbVlaDjVUwjItZKNtK6BomkobYNpUhjIrZCHKWhaWYmMqxnTNDGtqa4sD8mnqXQd_P2Ic1MpFg12ne_RjVBWtqSwKSOB8Ak3wMQa0ah3cSoeNoqC25lQyp_6aS4GPu-axWWH7gu9UpXs93R_T-s0rbers8vqf7nzKujjg00tWhzuVpkqufl0sFYeLL9dXv4Xa_lVNPCaVDw6DisZhb7B1Ac2gWu_-N-MZHaCcEg</recordid><startdate>197305</startdate><enddate>197305</enddate><creator>Fulmer Shealy, Y.</creator><creator>Clayton, Joe D.</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>197305</creationdate><title>Carbocyclic Analog of Purine Ribonucleosides with Antileukemic Activity</title><author>Fulmer Shealy, Y. ; Clayton, Joe D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4277-3e5d44f509086f2a67bafd603bb8ac02ac8c12f67364973f1ebc822a92c2b9ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1973</creationdate><topic>5-d]pyrimidine (carbocyclic analog of purine nucleoside)</topic><topic>5-d]pyrimidines-synthesis of 8-azaadenosine analog of purine nucleoside</topic><topic>antileukemic activity</topic><topic>Antileukemic activity-synthesis of a v-triazolo</topic><topic>Antileukemic activity—synthesis of a v-triazolo[4,5-d]pyrimidine (carbocyclic analog of purine nucleoside)</topic><topic>Aza Compounds - therapeutic use</topic><topic>Carbocyclic analogs of purine nucleosides (8- azaadenosine analog)—synthesis, antileukemic activity</topic><topic>Carbocyclic analogs of purine nucleosides (8-azaadenosine analog)-synthesis</topic><topic>Carcinoma, Squamous Cell - drug therapy</topic><topic>Cells, Cultured</topic><topic>Humans</topic><topic>Leukemia - drug therapy</topic><topic>Neoplasms, Experimental - drug therapy</topic><topic>Purine ribonucleosides-synthesis of carbocyclic analog with antileukemic activity</topic><topic>Purines - chemical synthesis</topic><topic>Purines - therapeutic use</topic><topic>Ribonucleosides - chemical synthesis</topic><topic>Ribonucleosides - therapeutic use</topic><topic>Triazoles - therapeutic use</topic><topic>v-Triazolo</topic><topic>v-Triazolo[4,5-d]pyrimidines—synthesis of 8-azaadenosine analog of purine nucleoside, antileukemic activity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fulmer Shealy, Y.</creatorcontrib><creatorcontrib>Clayton, Joe D.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fulmer Shealy, Y.</au><au>Clayton, Joe D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carbocyclic Analog of Purine Ribonucleosides with Antileukemic Activity</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>1973-05</date><risdate>1973</risdate><volume>62</volume><issue>5</issue><spage>858</spage><epage>859</epage><pages>858-859</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><abstract>Carbocyclic analogs of several naturally occurring and biologically active purine nucleosides have been synthesized (1–4). In these analogs a methylene group occupies the position of the ring oxygen atom of the ribo- or deoxyribofuranosides. Because of the presence of a stable carbon-nitrogen bond at position 9 of the purine moiety, these analogs are not subject to cleavage by enzymes that remove or transfer the ribofuranosyl moiety of the nucleosides or nucleotides. Biochemical studies (5–7) have shown that the racemic analog (III) of adenosine can serve either as a substrate for or as an inhibitor of some of the enzymes involved in purine nucleotide metabolism, one of the more interesting findings being the inhibition of guanylic acid kinase by the phosphate (7). The antibiotic aristeromycin (8). the optically active form (9, 10) of the adenosine analog, inhibits certain plant pathogens (8, 11). Several racemic carbocyclic analogs of purine nucleosides are cytotoxic to neoplastic cells growing in culture (4). In this communication, antileukemic activity in vivo by a carbocyclic analog, the 8-azaadenosine analog (II), is reported.</abstract><cop>Washington</cop><pub>Elsevier Inc</pub><pmid>4705710</pmid><doi>10.1002/jps.2600620547</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3549 |
ispartof | Journal of pharmaceutical sciences, 1973-05, Vol.62 (5), p.858-859 |
issn | 0022-3549 1520-6017 |
language | eng |
recordid | cdi_proquest_miscellaneous_81917330 |
source | Wiley-Blackwell Journals |
subjects | 5-d]pyrimidine (carbocyclic analog of purine nucleoside) 5-d]pyrimidines-synthesis of 8-azaadenosine analog of purine nucleoside antileukemic activity Antileukemic activity-synthesis of a v-triazolo Antileukemic activity—synthesis of a v-triazolo[4,5-d]pyrimidine (carbocyclic analog of purine nucleoside) Aza Compounds - therapeutic use Carbocyclic analogs of purine nucleosides (8- azaadenosine analog)—synthesis, antileukemic activity Carbocyclic analogs of purine nucleosides (8-azaadenosine analog)-synthesis Carcinoma, Squamous Cell - drug therapy Cells, Cultured Humans Leukemia - drug therapy Neoplasms, Experimental - drug therapy Purine ribonucleosides-synthesis of carbocyclic analog with antileukemic activity Purines - chemical synthesis Purines - therapeutic use Ribonucleosides - chemical synthesis Ribonucleosides - therapeutic use Triazoles - therapeutic use v-Triazolo v-Triazolo[4,5-d]pyrimidines—synthesis of 8-azaadenosine analog of purine nucleoside, antileukemic activity |
title | Carbocyclic Analog of Purine Ribonucleosides with Antileukemic Activity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T19%3A52%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carbocyclic%20Analog%20of%20Purine%20Ribonucleosides%20with%20Antileukemic%20Activity&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Fulmer%20Shealy,%20Y.&rft.date=1973-05&rft.volume=62&rft.issue=5&rft.spage=858&rft.epage=859&rft.pages=858-859&rft.issn=0022-3549&rft.eissn=1520-6017&rft_id=info:doi/10.1002/jps.2600620547&rft_dat=%3Cproquest_cross%3E81917330%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4277-3e5d44f509086f2a67bafd603bb8ac02ac8c12f67364973f1ebc822a92c2b9ff3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=81917330&rft_id=info:pmid/4705710&rfr_iscdi=true |